AmgenRecent Data Breaches and Security Report

https://amgen.com  ᛫  Biotech & Pharmaceuticals
Last updated October 18, 2018

Company Details

Company Overview

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2013, the company's largest selling product lines were Neulasta/Neupogen, two closely related drugs used to prevent infections in patients undergoing cancer chemotherapy; and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases.

Valuation

$122,404,352,000

Employees

26,640

CEO

Robert A. Bradway

Location

Thousand Oaks, CA, United States.

Recent Data Breaches

Stay informed about the most recent data breaches affecting companies like Amgen

subscribe to data breach notifications

Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's CSTAR Score ranges from 0 to 950. The higher the score, the more effective a company is in implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Amgen

Get full security report ›

See UpGuard In Action

Book a call with one of our specialists and we'll arrange a time for a demo.